肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 SITC临床实践指南：免疫效应细胞相关不良事件

2020-12-08 肿瘤免疫治疗学会 J Immunother Cancer . 2020 Dec;8(2):e001511.

肿瘤免疫治疗

2020年12月，肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南。免疫效应细胞（IEC）疗法为大量血液系统肿瘤患者提供了持久和持续的缓解。本文主要讨论了IEC治疗中常见毒性的识别和管理

中文标题：

2020 SITC临床实践指南：免疫效应细胞相关不良事件

英文标题：

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

发布机构：

肿瘤免疫治疗学会

发布日期：

2020-12-08

简要介绍：

2020年12月，肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南。免疫效应细胞（IEC）疗法为大量血液系统肿瘤患者提供了持久和持续的缓解。本文主要讨论了IEC治疗中常见毒性的识别和管理，包括实验室基本参数的监测，发病时间以及药物干预等，最终形成了循证共识和建议。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 SITC临床实践指南：免疫效应细胞相关不良事件.pdf)] GetToolGuiderByIdResponse(projectId=1, id=cb8cd1c00203337b, title=2020 SITC临床实践指南：免疫效应细胞相关不良事件, enTitle=Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events, guiderFrom=J Immunother Cancer . 2020 Dec;8(2):e001511., authorId=0, author=, summary=2020年12月，肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南。免疫效应细胞（IEC）疗法为大量血液系统肿瘤患者提供了持久和持续的缓解。本文主要讨论了IEC治疗中常见毒性的识别和管理, cover=https://img.medsci.cn/20201230/1609342909691_2020535.jpg, journalId=0, articlesId=null, associationId=1167, associationName=肿瘤免疫治疗学会, associationIntro=null, copyright=0, guiderPublishedTime=Tue Dec 08 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月，肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南。免疫效应细胞（IEC）疗法为大量血液系统肿瘤患者提供了持久和持续的缓解。本文主要讨论了IEC治疗中常见毒性的识别和管理，包括实验室基本参数的监测，发病时间以及药物干预等，最终形成了循证共识和建议。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1267, tagName=肿瘤免疫治疗)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1267, guiderKeyword=肿瘤免疫治疗, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=1825, appHits=67, showAppHits=0, pcHits=467, showPcHits=1758, likes=0, shares=0, comments=3, approvalStatus=1, publishedTime=Thu Dec 31 00:27:28 CST 2020, publishedTimeString=2020-12-08, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 30 23:41:55 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 09:28:39 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 SITC临床实践指南：免疫效应细胞相关不良事件.pdf)])
2020 SITC临床实践指南：免疫效应细胞相关不良事件.pdf
下载请点击：
评论区 (3)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=915584, encodeId=479591558418, content=很重要 积极学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da5b5428197, createdName=ms3000001625270051, createdTime=Mon Jan 11 14:58:46 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913262, encodeId=109b91326285, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a97e1895398, createdName=ms3316075004000287, createdTime=Sun Jan 03 11:13:20 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912440, encodeId=452d912440e7, content=关注肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=行米巴, createdTime=Thu Dec 31 08:16:16 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2021-01-11 ms3000001625270051

    很重要 积极学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=915584, encodeId=479591558418, content=很重要 积极学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da5b5428197, createdName=ms3000001625270051, createdTime=Mon Jan 11 14:58:46 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913262, encodeId=109b91326285, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a97e1895398, createdName=ms3316075004000287, createdTime=Sun Jan 03 11:13:20 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912440, encodeId=452d912440e7, content=关注肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=行米巴, createdTime=Thu Dec 31 08:16:16 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2021-01-03 ms3316075004000287

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=915584, encodeId=479591558418, content=很重要 积极学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=da5b5428197, createdName=ms3000001625270051, createdTime=Mon Jan 11 14:58:46 CST 2021, time=2021-01-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=913262, encodeId=109b91326285, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=103, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a97e1895398, createdName=ms3316075004000287, createdTime=Sun Jan 03 11:13:20 CST 2021, time=2021-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912440, encodeId=452d912440e7, content=关注肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=95, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=724a5448132, createdName=行米巴, createdTime=Thu Dec 31 08:16:16 CST 2020, time=2020-12-31, status=1, ipAttribution=)]
    2020-12-31 行米巴

    关注肿瘤免疫治疗学会(SITC)发布了免疫效应细胞相关不良事件指南

    0

拓展阅读

抗肿瘤治疗的免疫相关不良事件评价指导原则（征求意见稿）

国家药品监督管理局药品审评中心（CDE） · 2021-11-28

免疫检查点抑制剂相关的毒性多学科诊疗协作组建设中国专家共识

中国临床肿瘤学会免疫治疗专家委员会 · 2022-02-15